EUCTR2013-002124-17-ES进行中（未招募）1 期
Phase IV study to evaluate genetic variants of VEGF pathway as biomarkers of VEGF Trap-Eye treatment efficacy in subjects with neovascular age-related macular degeneration (wAMD). - BIOIMAGE
Fundació de Recerca de L?Institut de Microcirurgia Ocular0 个研究点开始时间: 2013年8月8日最近更新:
相关药物
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •? Men and women ? 50 years of age.
- •? Active primary subfoveal CNV lesions secondary to AMD, including juxtafoveal lesions that affect the fovea as evidenced by FA in the study eye.
- •? ETDRS best-corrected visual acuity of: 20/40 to 20/320 (letter score of 73 to 25) in the study eye at 4 meters.
- •? Willing, committed, and able to return for ALL clinic visits and complete all study-related procedures.
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range 70
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range 124
排除标准
- •? Any prior ocular (in the study eye) or systemic treatment or surgery for neovascular AMD,except dietary supplements or vitamins.
- •? Any prior or concomitant therapy with another investigational agent to treat neovascular AMD in the study eye.
- •? Prior treatment with anti-VEGF therapy in the study eye is not allowed
- •? No inflammation / infection in or around the eye
- •? Known hypersensitivity and allergies.
- •? Ocular surgery in the past other than cataract surgery.
- •? No other ocular disease that could lead to decrease of VA.
研究者
相似试验
进行中（未招募）
1 期
Treatment of solid tumors with genetically modified patients' own T-cells recognizing a particular tumor markerRecurrent and / or refractory solid tumorsMedDRA version: 21.1Level: LLTClassification code 10065252Term: Solid tumorSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)EUCTR2019-002370-31-DEImmatics US InC476
已完成
不适用
Genetic study to identify genetic variants which affect clinical severity in Thai patients with beta thalassemia hemoglobin Eclinical variation in patients with beta thalassemia Hb E diseasebeta thalassemia Hb E disease, Thailand, genetic modifierTCTR20211022001Siriraj Hospital338
Enrolling By Invitation
不适用
Pilot Study to Evaluate the Contribution of Gene Variants to Idiopathic UrolithiasisKidney StonesCalcium Oxalate UrolithiasisUrolithiasisNCT01127854Mayo Clinic2,900
进行中（未招募）
不适用
Pilot study of association of VEGF polymorphisms with clinical efficacy and tolerability of therapy in patients affected by exudative (neovascular) age-related macular degeneration. - DEGENEExudative and atrophic age-related macular degeneration.MedDRA version: 6.1Level: PTClassification code 10025409EUCTR2007-004487-53-ITAZIENDA OSPEDALIERA PISANA
进行中（未招募）
不适用
A prospective clinical trial to evaluate the V4 Drug delivery device for long term delivery of Ranibizumab for the Treatment of Choroidal Neovascularization” - Drug Delivery Device for Long Term Delivery of Ranibizumab for the Treatment of Choroidal NeovasculaEUCTR2010-023923-78-ATForsight Vision 4, Inc.